Innate and acquired immunity in atherogenesis (original) (raw)

• Tuzcu, E.M. et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: Evidence from intravascular ultrasound. Circulation 103, 2705–2710 (2001).
  Article CAS PubMed Google Scholar
• Leitersdorf, E., Tobin, E.J., Davignon, J. & Hobbs, H.H. Common low-density lipoprotein receptor mutations in the French Canadian population. J. Clin. Invest. 85, 1014–1023 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Glass, C.K. & Witztum, J.L. Atherosclerosis: The road ahead. Cell 104, 503–516 (2001).
  Article CAS PubMed Google Scholar
• Hansson, G.K., Libby, P., Schonbeck, U. & Yan, Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91, 281–291 (2002).
  Article CAS PubMed Google Scholar
• Hansson, G.K. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21, 1876–1890 (2001).
  Article CAS PubMed Google Scholar
• Hörkkö, S. et al. Immunological responses to oxidized LDL. Free Radic. Biol. Med. 28, 1771–1779 (2000).
  Article PubMed Google Scholar
• Ross, R. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999).
  Article CAS PubMed Google Scholar
• Libby, P., Ridker, P.M. & Maseri, A. Inflammation and atherosclerosis. Circulation 105, 1135–1143 (2002).
  Article CAS PubMed Google Scholar
• Williams, K.J. & Tabas, I. The response-to-retention hypothesis of atherogenesis reinforced. Curr. Opin. Lipidol. 9, 471–474 (1998).
  Article CAS PubMed Google Scholar
• Skalen, K. et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417, 750–754 (2002).
  Article CAS PubMed Google Scholar
• Gaut, J.P. & Heinecke, J.W. Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis. Trends Cardiovasc. Med. 11, 103–112 (2001).
  Article CAS PubMed Google Scholar
• Pratico, D. Lipid peroxidation in mouse models of atherosclerosis. Trends Cardiovasc. Med. 11, 112–116 (2001).
  Article CAS PubMed Google Scholar
• Colles, S.M., Maxson, J.M., Carlson, S.G. & Chisolm, G.M. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc. Med. 11, 131–138 (2001).
  Article CAS PubMed Google Scholar
• Berliner, J.A., Subbanagounder, G., Leitinger, N., Watson, A.D. & Vora, D. Evidence for a role of phospholipid oxidation products in atherogenesis. Trends Cardiovasc. Med. 11, 142–147 (2001).
  Article CAS PubMed Google Scholar
• Marathe, G.K., Prescott, S.M., Zimmerman, G.A. & McIntyre, T.M. Oxidized LDL contains inflammatory PAF-like phospholipids. Trends Cardiovasc. Med. 11, 139–142 (2001).
  Article CAS PubMed Google Scholar
• Witztum, J.L. & Steinberg, D. The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? Trends Cardiovasc. Med. 11, 93–102 (2001).
  Article CAS PubMed Google Scholar
• Suzuki, H. et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292–296 (1997).
  Article CAS PubMed Google Scholar
• Febbraio, M. et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105, 1049–1056 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Libby, P., Egan, D. & Skarlatos, S. Roles of infectious agents in atherosclerosis and restenosis: An assessment of the evidence and need for future research. Circulation 96, 4095–4103 (1997).
  Article CAS PubMed Google Scholar
• Landmesser, U. & Harrison, D.G. Oxidant stress as a marker for cardiovascular events—Ox marks the spot. Circulation 104, 2638–2640 (2001).
  Article CAS PubMed Google Scholar
• Dansky, H.M., Charlton, S.A., Harper, M.M. & Smith, J.D. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 94, 4642–4646 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Daugherty, A. et al. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E−/− mice. J. Clin. Invest. 100, 1575–1580 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Song, L., Leung, C. & Schindler, C. Lymphocytes are important in early atherosclerosis. J. Clin. Invest. 108, 251–259 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Reardon, C.A. et al. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21, 1011–1016 (2001).
  Article CAS PubMed Google Scholar
• Zhou, X., Nicoletti, A., Elhage, R. & Hansson, G.K. Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102, 2919–2922 (2000).
  Article CAS PubMed Google Scholar
• Palinski, W., Miller, E. & Witztum, J.L. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA 92, 821–825 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Ameli, S. et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. 16, 1074–1079 (1996).
  Article CAS PubMed Google Scholar
• Freigang, S., Hörkkö, S., Miller, E., Witztum, J.L. & Palinski, W. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler. Thromb. Vasc. Biol. 18, 1972–1982 (1998).
  Article CAS PubMed Google Scholar
• George, J. et al. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138, 147–152 (1998).
  Article CAS PubMed Google Scholar
• Zhou, X., Caligiuri, G., Hamsten, A., Lefvert, A.K. & Hansson, G.K. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21, 108–114 (2001).
  Article CAS PubMed Google Scholar
• Nicoletti, A., Kaveri, S., Caligiuri, G., Bariaety, J. & Hansson, G.K. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J. Clin. Invest. 102, 910–918 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Medzhitov, R. & Janeway, C.A., Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296, 298–300 (2002).
  Article CAS PubMed Google Scholar
• Medzhitov, R. Toll-like receptors and innate immunity. Nature Rev. Immunol. 1, 135–145 (2001).
  Article CAS Google Scholar
• Gosling, J. et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103, 773–778 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Boring, L., Gosling, J., Cleary, M. & Charo, I.F. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894–897 (1998).
  Article CAS PubMed Google Scholar
• Smith, J.D. et al. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA 92, 8264–8268 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Cybulsky, M.I. & Gimbrone, M.A., Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788–791 (1991).
  Article CAS PubMed Google Scholar
• Witztum, J.L. & Berliner, J.A. Oxidized phospholipids and isoprostanes in atherosclerosis. Curr. Opin. Lipidol. 9, 441–448 (1998).
  Article CAS PubMed Google Scholar
• Edfeldt, K., Swedenborg, J., Hansson, G.K. & Yan, Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation 105, 1158–1161 (2002).
  Article CAS PubMed Google Scholar
• Wright, S.D. et al. Infectious agents are not necessary for murine atherogenesis. J. Exp. Med. 191, 1437–1442 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kiechl, S. et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347, 185–192 (2002).
  Article CAS PubMed Google Scholar
• Hubacek, J.A. et al. C(−260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99, 3218–3220 (1999).
  Article CAS PubMed Google Scholar
• Li, A.C. & Glass, C.K. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 8, 1235–1242 (2002).
  Article CAS PubMed Google Scholar
• Vlaicu, R., Niculescu, F., Rus, H.G. & Cristea, A. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 57, 163–177 (1985).
  Article CAS PubMed Google Scholar
• Buono, C. et al. Influence of C3 deficiency on atherosclerosis. Circulation 105, 3025–3031 (2002).
  Article CAS PubMed Google Scholar
• Volanakis, J.E. Human C-reactive protein: Expression, structure, and function. Mol. Immunol. 38, 189–197 (2001).
  Article CAS PubMed Google Scholar
• Yasojima, K., Schwab, C., McGeer, E.G. & McGeer, P.L. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am. J. Pathol. 158, 1039–1051 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Shaw, P.X. et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105, 1731–1740 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Vos, Q., Lees, A., Wu, Z.Q., Snapper, C.M. & Mond, J.J. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176, 154–170 (2000).
  Article CAS PubMed Google Scholar
• Ochsenbein, A.F. et al. Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: Implications for splenectomized patients and vaccine design. J. Immunol. 164, 6296–6302 (2000).
  Article CAS PubMed Google Scholar
• Millonig, G., Schwentner, C., Mueller, P., Mayerl, C. & Wick, G. The vascular-associated lymphoid tissue: A new site of local immunity. Curr. Opin. Lipidol. 12, 547–553 (2001).
  Article CAS PubMed Google Scholar
• Schiller, N.K., Boisvert, W.A. & Curtiss, L.K. Lesion formation in LDL receptor–deficient mice with perforin and _Lyst_beige mutations. Arterioscler. Thromb. Vasc. Biol. 22, 1341–1346 (2002).
  Article CAS PubMed Google Scholar
• Sohma, Y. et al. Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Proc. Natl. Acad. Sci. USA 92, 4937–4941 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, X. & Hansson, G.K. Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand. J. Immunol. 50, 25–30 (1999).
  Article CAS PubMed Google Scholar
• Mach, F. et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 94, 1931–1936 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Lutgens, E. et al. Requirement for CD154 in the progression of atherosclerosis. Nature Med. 5, 1313–1316 (1999).
  Article CAS PubMed Google Scholar
• Mach, F., Schönbeck, U., Sukhova, G.K., Atkinson, E. & Libby, P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394, 200–203 (1998).
  Article CAS PubMed Google Scholar
• Schönbeck, U., Sukhova, G.K., Shimizu, K., Mach, F. & Libby, P. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 97, 7458–7463 (2000).
  Article PubMed PubMed Central Google Scholar
• Lutgens, E. et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc. Natl. Acad. Sci. USA 97, 7464–7469 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Uyemura, K. et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J. Clin. Invest. 97, 2130–2138 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Gerdes, N. et al. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for atherogenesis. J. Exp. Med. 195, 245–257 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Gupta, S. et al. IFN-γ potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752–2761 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Whitman, S.C., Ravisankar, P., Elam, H. & Daugherty, A. Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E−/− mice. Am. J. Pathol. 157, 1819–1824 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, T.S., Yen, H.C., Pan, C.C. & Chau, L.Y. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19, 734–742 (1999).
  Article CAS PubMed Google Scholar
• Whitman, S.C., Ravisankar, P. & Daugherty, A. Interleukin-18 enhances atherosclerosis in apolipoprotein E−/− mice through release of interferon-γ. Circ. Res. 90, E34–E38 (2002).
  Article CAS PubMed Google Scholar
• Pinderski, L.J. et al. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ. Res. 90, 1064–1071 (2002).
  Article CAS PubMed Google Scholar
• Laurat, E. et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 104, 197–202 (2001).
  Article CAS PubMed Google Scholar
• Huber, S.A., Sakkinen, P., David, C., Newell, M.K. & Tracy, R.P. T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103, 2610–2616 (2001).
  Article CAS PubMed Google Scholar
• King, V.L., Szilvassy S.J. & Daugherty A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor−/− mice. Arterioscler. Thromb. Vasc. Biol. 22, 456–461 (2002).
  Article CAS PubMed Google Scholar
• Mallat, Z. et al. Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 89, 930–934 (2001).
  Article CAS PubMed Google Scholar
• Lutgens, E. et al. Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression. Arterioscler. Thromb. Vasc. Biol. 22, 975–982 (2002).
  Article CAS PubMed Google Scholar
• Caligiuri, G., Nicoletti, A., Poirier, B. & Hansson, G.K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109, 745–753 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Witztum, J.L. Splenic immunity and atherosclerosis: A glimpse into a novel paradigm? J. Clin. Invest. 109, 721–724 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Robinette, C.D. & Fraumeni, J.F., Jr. Splenectomy and subsequent mortality in veterans of the 1939–45 war. Lancet 2, 127–129 (1977).
  Article CAS PubMed Google Scholar
• Paulsson, G., Zhou, X., Tornquist, E. & Hansson, G.K. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20, 10–17 (2000).
  Article CAS PubMed Google Scholar
• George, J. et al. Adoptive transfer of β2-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102, 1822–1827 (2000).
  Article CAS PubMed Google Scholar
• Beck, J.D., Pankow, J., Tyroler, H.A. & Offenbacher, S. Dental infections and atherosclerosis. Am. Heart J. 138, S528–S533 (1999).
  Article CAS PubMed Google Scholar
• Wick, G., Perschinka, H. & Millonig, G. Atherosclerosis as an autoimmune disease: An update. Trends Immunol. 22, 665–669 (2001).
  Article CAS PubMed Google Scholar
• Mayr, M., Kiechl, S., Willeit, J., Wick, G. & Xu, Q. Infections, immunity, and atherosclerosis: Associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102, 833–839 (2000).
  Article CAS PubMed Google Scholar
• Afek, A. et al. Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J. Autoimmun. 14, 115–121 (2000).
  Article CAS PubMed Google Scholar
• Maron, R. et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 106, 1708–1715 (2002).
  Article CAS PubMed Google Scholar
• Palinski, W. & Witztum, J.L. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J. Intern. Med. 247, 371–380 (2000).
  Article CAS PubMed Google Scholar
• Gillotte, K.L., Hörkkö, S., Witztum, J.L. & Steinberg, D. Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors. J. Lipid Res. 41, 824–833 (2000).
  CAS PubMed Google Scholar
• Friedman, P., Hörkkö, S., Steinberg, D., Witztum, J.L. & Dennis, E.A. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol concentration. J. Biol. Chem. 277, 7010–7020 (2002).
  Article CAS PubMed Google Scholar
• Ylä-Herttuala, S. et al. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14, 32–40 (1994).
  Article PubMed Google Scholar
• Cyrus, T. et al. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation 103, 2277–2282 (2001).
  Article CAS PubMed Google Scholar
• Tsimikas, S., Palinski, W. & Witztum, J.L. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21, 95–100 (2001).
  Article CAS PubMed Google Scholar
• Stemme, S. et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 92, 3893–3897 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Palinski, W. et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98, 800–814 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Hörkkö, S. et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103, 117–128 (1999).
  Article PubMed PubMed Central Google Scholar
• Gillotte-Taylor, K., Boullier, A., Witztum, J.L., Steinberg, D. & Quehenberger, O. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J. Lipid Res. 42, 1474–1482 (2001).
  CAS PubMed Google Scholar
• Boullier, A. et al. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J. Biol. Chem. 275, 9163–9169 (2000).
  Article CAS PubMed Google Scholar
• Podrez, E.A. et al. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 277, 38503–38516 (2002).
  Article CAS PubMed Google Scholar
• Podrez, E.A. et al. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 277, 38517–38523 (2002).
  Article CAS PubMed Google Scholar
• Chang, M.K. et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA 96, 6353–6358 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Briles, D.E., Forman, C., Hudak, S. & Claflin, J.L. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J. Exp. Med. 156, 1177–1185 (1982).
  Article CAS PubMed Google Scholar
• Gershov, D., Kim, S., Brot, N. & Elkon, K.B. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity. J. Exp. Med. 192, 1353–1364 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Chang, M.K., Binder, C.J., Torzewski, M. & Witztum, J.L. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc. Natl. Acad. Sci. USA 99, 13043–13048 (2002).
  Article CAS PubMed PubMed Central Google Scholar